Cargando…
P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072139/ http://dx.doi.org/10.1186/2051-1426-2-S2-P4 |
_version_ | 1782322910579392512 |
---|---|
author | Kowanetz, M Vu, MT Wu, J Koeppen, H Kohrt, H Gettinger, S Cruz, C Denker, M Chen, DS Hegde, P |
author_facet | Kowanetz, M Vu, MT Wu, J Koeppen, H Kohrt, H Gettinger, S Cruz, C Denker, M Chen, DS Hegde, P |
author_sort | Kowanetz, M |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4072139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40721392014-06-27 P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A) Kowanetz, M Vu, MT Wu, J Koeppen, H Kohrt, H Gettinger, S Cruz, C Denker, M Chen, DS Hegde, P J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072139/ http://dx.doi.org/10.1186/2051-1426-2-S2-P4 Text en Copyright © 2014 Kowanetz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Kowanetz, M Vu, MT Wu, J Koeppen, H Kohrt, H Gettinger, S Cruz, C Denker, M Chen, DS Hegde, P P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A) |
title | P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A) |
title_full | P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A) |
title_fullStr | P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A) |
title_full_unstemmed | P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A) |
title_short | P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A) |
title_sort | p13. intra-tumoral and surrogate immune responses in patients treated with the engineered anti-pd-l1 antibody (mpdl3280a) |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072139/ http://dx.doi.org/10.1186/2051-1426-2-S2-P4 |
work_keys_str_mv | AT kowanetzm p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a AT vumt p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a AT wuj p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a AT koeppenh p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a AT kohrth p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a AT gettingers p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a AT cruzc p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a AT denkerm p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a AT chends p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a AT hegdep p13intratumoralandsurrogateimmuneresponsesinpatientstreatedwiththeengineeredantipdl1antibodympdl3280a |